Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

Economic aspects of infertility care: a challenge for researchers and clinicians.

ESHRE Capri Workshop Group.

Hum Reprod. 2015 Jul 3. pii: dev163. [Epub ahead of print] Review.

PMID:
26141712
2.

Is it justified to transfer two embryos in oocyte donation? A pilot randomized clinical trial.

Clua E, Tur R, Coroleu B, Rodríguez I, Boada M, Gómez MJ, Barri PN, Veiga A.

Reprod Biomed Online. 2015 May 11. pii: S1472-6483(15)00205-9. doi: 10.1016/j.rbmo.2015.04.013. [Epub ahead of print]

PMID:
26096029
3.

Comparison of starting ovarian stimulation on day 2 versus day 15 of the menstrual cycle in the same oocyte donor and pregnancy rates among the corresponding recipients of vitrified oocytes.

Martínez F, Clua E, Devesa M, Rodríguez I, Arroyo G, González C, Solé M, Tur R, Coroleu B, Barri PN.

Fertil Steril. 2014 Nov;102(5):1307-11. doi: 10.1016/j.fertnstert.2014.07.741. Epub 2014 Aug 22.

PMID:
25154677
4.

Live birth using vitrified--warmed oocytes in invasive ovarian cancer: case report and literature review.

Alvarez M, Solé M, Devesa M, Fábregas R, Boada M, Tur R, Coroleu B, Veiga A, Barri PN.

Reprod Biomed Online. 2014 Jun;28(6):663-8. doi: 10.1016/j.rbmo.2014.02.010. Epub 2014 Mar 4. Review.

PMID:
24745835
5.

Long-term treatment of uterine fibroids with ulipristal acetate ☆.

Donnez J, Vázquez F, Tomaszewski J, Nouri K, Bouchard P, Fauser BC, Barlow DH, Palacios S, Donnez O, Bestel E, Osterloh I, Loumaye E; PEARL III and PEARL III Extension Study Group.

Fertil Steril. 2014 Jun;101(6):1565-73.e1-18. doi: 10.1016/j.fertnstert.2014.02.008. Epub 2014 Mar 12.

6.

Ovarian response to controlled ovarian hyperstimulation in women with cancer is as expected according to an age-specific nomogram.

Devesa M, Martínez F, Coroleu B, Rodríguez I, González C, Barri PN.

J Assist Reprod Genet. 2014 May;31(5):583-8. doi: 10.1007/s10815-014-0183-6. Epub 2014 Feb 4.

7.

Investigations into implantation failure in oocyte-donation recipients.

Barri PN, Coroleu B, Clua E, Tur R, Boada M, Rodriguez I.

Reprod Biomed Online. 2014 Jan;28(1):99-105. doi: 10.1016/j.rbmo.2013.08.012. Epub 2013 Sep 24.

PMID:
24268727
8.

Does culture medium influence offspring birth weight?

Carrasco B, Boada M, Rodríguez I, Coroleu B, Barri PN, Veiga A.

Fertil Steril. 2013 Nov;100(5):1283-8. doi: 10.1016/j.fertnstert.2013.07.006. Epub 2013 Aug 2.

PMID:
23916797
9.

Endometriosis and IVF: are agonists really better? Analysis of 1180 cycles with the propensity score matching.

Rodriguez-Purata J, Coroleu B, Tur R, Carrasco B, Rodriguez I, Barri PN.

Gynecol Endocrinol. 2013 Sep;29(9):859-62. doi: 10.3109/09513590.2013.808327. Epub 2013 Jul 22.

PMID:
23875964
10.

Have antimüllerian hormone and antral follicle count been given the same opportunities?

Martínez F, Devesa M, Barri PN.

Fertil Steril. 2013 Aug;100(2):e9. doi: 10.1016/j.fertnstert.2013.05.049. Epub 2013 Jun 27. No abstract available.

PMID:
23809498
11.

Is AMH useful to reduce low ovarian response to GnRH antagonist protocol in oocyte donors?

Martínez F, Clua E, Carreras O, Tur R, Rodríguez I, Barri PN.

Gynecol Endocrinol. 2013 Aug;29(8):754-7. doi: 10.3109/09513590.2013.801443. Epub 2013 Jun 12.

PMID:
23758138
12.

How does vitrification affect oocyte viability in oocyte donation cycles? A prospective study to compare outcomes achieved with fresh versus vitrified sibling oocytes.

Solé M, Santaló J, Boada M, Clua E, Rodríguez I, Martínez F, Coroleu B, Barri PN, Veiga A.

Hum Reprod. 2013 Aug;28(8):2087-92. doi: 10.1093/humrep/det242. Epub 2013 Jun 5.

13.

Cancer and fertility preservation: Barcelona consensus meeting.

Martínez F, Devesa M, Coroleu B, Tur R, González C, Boada M, Solé M, Veiga A, Barri PN.

Gynecol Endocrinol. 2013 Apr;29(4):285-91. doi: 10.3109/09513590.2012.743019. Epub 2013 Jan 24. Review.

PMID:
23347067
14.

Elective single-embryo transfer in oocyte donation programmes: Should it be the rule?

Clua E, Tur R, Coroleu B, Boada M, Rodríguez I, Barri PN, Veiga A.

Reprod Biomed Online. 2012 Dec;25(6):642-8. doi: 10.1016/j.rbmo.2012.09.008. Epub 2012 Sep 21.

PMID:
23069742
15.

Vitrified blastocysts from Preimplantation Genetic Diagnosis (PGD) as a source for human Embryonic Stem Cell (hESC) derivation.

Aran B, Sole M, Rodriguez-Pizà I, Parriego M, Muñoz Y, Boada M, Barri PN, Izpisúa JC, Veiga A.

J Assist Reprod Genet. 2012 Oct;29(10):1013-20. doi: 10.1007/s10815-012-9820-0. Epub 2012 Jun 27.

16.

Triggering ovulation with 250 μg or 500 μg of r-hCG in oocyte donors treated with antagonist protocol has no effect on the number of mature oocytes retrieved: a randomized clinical trial.

Clua E, Martínez F, Tur R, Sanmartín P, Chueca A, Barri PN.

Gynecol Endocrinol. 2012 Sep;28(9):678-81. doi: 10.3109/09513590.2011.652244. Epub 2012 Feb 4.

PMID:
22304627
17.

Ulipristal acetate versus leuprolide acetate for uterine fibroids.

Donnez J, Tomaszewski J, Vázquez F, Bouchard P, Lemieszczuk B, Baró F, Nouri K, Selvaggi L, Sodowski K, Bestel E, Terrill P, Osterloh I, Loumaye E; PEARL II Study Group.

N Engl J Med. 2012 Feb 2;366(5):421-32. doi: 10.1056/NEJMoa1103180.

18.

Combined strategy for fertility preservation in an oncologic patient: vitrification of in vitro matured oocytes and ovarian tissue freezing.

González C, Devesa M, Boada M, Coroleu B, Veiga A, Barri PN.

J Assist Reprod Genet. 2011 Dec;28(12):1147-9. doi: 10.1007/s10815-011-9628-3. Epub 2011 Sep 2. No abstract available.

19.

Heterotopic pregnancy in a cross border oocyte donation patient: the importance of cooperation between centers.

Mancini F, Clua E, Martínez F, Battaglia C, Veiga A, Barri PN.

Fertil Steril. 2011 Jun;95(7):2432.e13-5. doi: 10.1016/j.fertnstert.2011.03.092.

PMID:
21601667
20.

Prevention of prematurity by single embryo transfer.

Barri PN, Coroleu B, Clua E, Tur R.

J Perinat Med. 2011 May;39(3):237-40. doi: 10.1515/JPM.2011.020. Epub 2011 May 3. Review.

PMID:
21534880
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk